Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prognosis and Predicting Genetic Study of Lung Cancer

NCT03234179 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03234179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03234179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prognosis and Predicting Genetic Study of Lung Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2017
Completion date
August 1, 2037
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

genetic predisposition to disease, lung cancer